Avaiable Dossiers
Last update: October 2019
Alimentary Tract & Metabolism
| PRODUCT NAME | PHARMACEUTICAL FORM | STRENGTH | |
|---|---|---|---|
| Esomeprazole (sodium) | Powder for solution for infusion or injection | 40 mg | |
| Linagliptin* | Film-coated tablets | 5 mg | |
| Omeprazole | Powder for solution for infusion | 40 mg | |
| Orlistat OTC | Hard capsules | 60 mg | |
| Orlistat | Hard capsules | 120 mg | |
| Pantoprazole (sodium sesquihydrate) | Powder for solution for injection | 40 mg | |
| Sitagliptin (hydrochloride) | Film-coated tablets |
25 mg 50 mg 100 mg | |
| Sitagliptin (hydrochloride) / Metformin | Film-coated tablets |
50 mg / 850 mg 50 mg / 1000 mg |
Anti-infective for Systemic Use
| PRODUCT NAME | PHARMACEUTICAL FORM | STRENGTH |
|---|---|---|
| Aciclovir | Tablets |
200 mg 400 mg 800 mg |
| Clarithromycin | Powder for solution for infusion | 500 mg |
| Tenofovir disoproxil (fumarate) | Film-coated tablets | 245 mg |
| Voriconazole | Film-coated tablets |
50 mg 200 mg |
Blood & Blood Forming Organs
| PRODUCT NAME | PHARMACEUTICAL FORM | STRENGTH |
|---|---|---|
| Acetylsalicylic acid | Gastro-resistant coated tablets |
75 mg 150 mg |
| Apixaban* | Film-coated tablets |
2.5 mg 5 mg |
| Rivaroxaban * (CA) | Film-coated tablets |
2.5 mg 10 mg 15 mg 20 mg |
| Ticagrelor * | Film-coated tablets |
60 mg 90 mg |
Cardiovascular System
| PRODUCT NAME | PHARMACEUTICAL FORM | STRENGTH |
|---|---|---|
|
Amlodipine (besilate) + Atorvastatin (calcium) | Film-coated tablets |
5/10 mg 10/10 mg 5/20 mg 10/20 mg |
| Amlodipine (maleate) + Valsartan | Film-coated tablets |
5/80 mg 5/160 mg 10/160 mg |
|
Amlodipine (maleate) + Valsartan + Hydrochlorothiazide* | Film-coated tablets |
5/160/12.5 mg 10/160/12.5 mg 10/320/25 mg 10/160/25 mg 5/160/25 mg |
| Bosentan * | Film-coated tablets |
62.5 mg 125 mg |
| Hydrochlorothiazide * | Tablets |
12.5 mg 25 mg 50 mg |
| Metoprolol tartrate | Solution for injection | 1 mg/ml (5ml) |
| Ramipril + Amlodipine (besilate) | Hard Capsules |
5/5 mg 5/10 mg 10/5 mg 10/10 mg |
| Rosuvastatin (calcium)* | Film-coated tablets |
5 mg + 10 mg 20 mg + 40 mg |
| Sildenafil (citrate)* | Film-coated tablets | 20 mg |
| Telmisartan / Amlodipine | Tablets |
40/10 mg 40/5 mg 80/10 mg 80/5 mg |
Dermatologicals
| PRODUCT NAME | PHARMACEUTICAL FORM | STRENGTH | |
|---|---|---|---|
| Dimetindene OTC | Gel | 1 mg/g (20g, 30g, 50g) |
For more information regarding available dossiers, please contact us or download the dossier list with extended information here
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
* Polpharma Group API, (CA) Dossier also available for Canadian market, (*) Stability zone IVb on-going only for strawberry flavour, (**) Dossier update not earlier than Q3 2019, (***) Dossier availability subject to some restrictions
We Offer
High level of customer service
Excellent products with CTD dossiers meeting EU requirements
Regulatory knowledge and expertise
Full support in developing registration strategies
to meet the needs of our customers
Execution and support in registration procedures upon customer’s request
QA service and pharmacovigilance service (PSUR)
Intellectual property expertise
Highly skilled and professional team of Project Managers
Partnership in a win-win strategy